高级检索
当前位置: 首页 > 详情页

Expanded CD4+CXCR5-PD-1+peripheral T helper like cells and clinical significance in IgG4-related disease

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China [2]Minist Sci & Technol, Natl Clin Res Ctr Dermatol & Immunol Dis NCRC DID, Beijing 100730, Peoples R China [3]Peking Union Med Coll Hosp PUMCH, State Key Lab Complex Severe & Rare Dis, Beijing 100730, Peoples R China [4]Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100730, Peoples R China [5]Zhengzhou Univ, Affiliated Hosp 1, Dept Rheumatol & Immunol, Zhengzhou, Peoples R China [6]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Stomatol, Beijing, Peoples R China [7]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Rheumatol, Wuhan, Peoples R China [8]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China
出处:
ISSN:

关键词: IgG4-RD Tph like cells Plasmablast Disease monitoring

摘要:
To identify the phenotypic features and clinical significance of peripheral T helper (Tph) like cells in IgG4-RD, 54 untreated IgG4-RD patients and 57 healthy controls (HCs) were enrolled. Flow cytometry analysis, ELISA and correlation analysis were performed. Results indicated that percentages of CD4 + CXCR5-PD-1+ Tph like cells in the peripheral blood of IgG4-RD patients were significantly higher than those of HCs (2.27% +/- 1.99% vs 1.12% +/- 0.98%, P < 0.001). Expression of CD38, CD25, and TIGIT was higher, whereas that of CCR7, CD127 was lower in the Tph like cells from the IgG4-RD patients than in those from the HCs. The IgG4-RD patients with affected internal organs had higher circulating Tph like cell levels than those without (2.69% +/- 1.99% vs 1.23% +/- 0.93%, respectively, P = 0.003). In addition, Tph like cells correlated with serum IgG and IgG4 and peripheral plasmablast levels which could be a promising biomarker for disease activity monitoring.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 医学
小类 | 3 区 免疫学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 免疫学
JCR分区:
出版当年[2020]版:
Q3 IMMUNOLOGY
最新[2024]版:
Q2 IMMUNOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China [2]Minist Sci & Technol, Natl Clin Res Ctr Dermatol & Immunol Dis NCRC DID, Beijing 100730, Peoples R China [3]Peking Union Med Coll Hosp PUMCH, State Key Lab Complex Severe & Rare Dis, Beijing 100730, Peoples R China [4]Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100730, Peoples R China [5]Zhengzhou Univ, Affiliated Hosp 1, Dept Rheumatol & Immunol, Zhengzhou, Peoples R China
通讯作者:
通讯机构: [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China [2]Minist Sci & Technol, Natl Clin Res Ctr Dermatol & Immunol Dis NCRC DID, Beijing 100730, Peoples R China [3]Peking Union Med Coll Hosp PUMCH, State Key Lab Complex Severe & Rare Dis, Beijing 100730, Peoples R China [4]Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100730, Peoples R China [*1]Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, 1 Shuai Fu Yuan, Beijing 100730, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)